Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Shore

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Urology|September 25, 2017
Author ReplyNeal Shore, Axel Heidenreich, Fred Saad
Urology|August 12, 2017
Predicting Response and Recognizing Resistance: Improving Outcomes in Patients With Castration-resistant Prostate CancerNeal Shore, Axel Heidenreich, Fred Saad
The Urologic Clinics of North America|April 2, 2021
The Growth of Integrated Care Models in UrologyCaitlin Shepherd, Michael Cookson, Neal Shore
Therapeutic Advances in Urology|February 6, 2019
Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasiaNeal Shore, Ronald Tutrone, Claus G Roehrborn
Current Opinion in Urology|May 13, 2022
Review of second-generation androgen receptor inhibitor therapies and their role in prostate cancer managementSeyed Behzad Jazayeri, Abhishek Srivastava, Neal Shore
Journal of Comparative Effectiveness Research|February 16, 2026
Real-world clinical outcomes of patients with localized prostate cancer treated with radical prostatectomy in SEER-MedicareLawrence Karsh, Shawn Du, Jinghua He, et al.
BJU International|August 20, 2011
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancerNeal Shore, Michael S Cookson, Marc C Gittelman
JAMA Network Open|December 9, 2024
In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?Jason R Brown, Neal Shore, Pedro C Barata
Prostate Cancer and Prostatic Diseases|February 9, 2021
Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitorsFred Saad, Martin Bögemann, Kazuhiro Suzuki, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2018
Current approaches to incorporation of radium-223 in clinical practiceChris Parker, Axel Heidenreich, Sten Nilsson, et al.
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Urology|September 25, 2017
Author ReplyNeal Shore, Axel Heidenreich, Fred Saad
Urology|August 12, 2017
Predicting Response and Recognizing Resistance: Improving Outcomes in Patients With Castration-resistant Prostate CancerNeal Shore, Axel Heidenreich, Fred Saad
The Urologic Clinics of North America|April 2, 2021
The Growth of Integrated Care Models in UrologyCaitlin Shepherd, Michael Cookson, Neal Shore
Therapeutic Advances in Urology|February 6, 2019
Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasiaNeal Shore, Ronald Tutrone, Claus G Roehrborn
Current Opinion in Urology|May 13, 2022
Review of second-generation androgen receptor inhibitor therapies and their role in prostate cancer managementSeyed Behzad Jazayeri, Abhishek Srivastava, Neal Shore
Journal of Comparative Effectiveness Research|February 16, 2026
Real-world clinical outcomes of patients with localized prostate cancer treated with radical prostatectomy in SEER-MedicareLawrence Karsh, Shawn Du, Jinghua He, et al.
BJU International|August 20, 2011
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancerNeal Shore, Michael S Cookson, Marc C Gittelman
JAMA Network Open|December 9, 2024
In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?Jason R Brown, Neal Shore, Pedro C Barata
Prostate Cancer and Prostatic Diseases|February 9, 2021
Treatment of nonmetastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitorsFred Saad, Martin Bögemann, Kazuhiro Suzuki, et al.
Prostate Cancer and Prostatic Diseases|January 5, 2018
Current approaches to incorporation of radium-223 in clinical practiceChris Parker, Axel Heidenreich, Sten Nilsson, et al.
Pageof 20